Schiel, J. E., Davis, D. L., & Borisov, O. (2015). State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization volume 2: Biopharmaceutical characterization: the NISTmAb case study. American Chemical Society.
Chicago-referens (17:e uppl.)Schiel, John E., Darryl L. Davis, och Oleg Borisov. State-of-the-art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2: Biopharmaceutical Characterization: The NISTmAb Case Study. Washington, DC: American Chemical Society, 2015.
MLA-referens (9:e uppl.)Schiel, John E., et al. State-of-the-art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2: Biopharmaceutical Characterization: The NISTmAb Case Study. American Chemical Society, 2015.